Form 8-K - Current report:
SEC Accession No. 0001104659-24-103773
Filing Date
2024-09-27
Accepted
2024-09-27 17:10:55
Documents
13
Period of Report
2024-09-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425081d1_8k.htm   iXBRL 8-K 26660
  Complete submission text file 0001104659-24-103773.txt   198496

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20240924.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20240924_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20240924_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2425081d1_8k_htm.xml XML 3597
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 241335929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)